Compare CHNR & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHNR | MNDR |
|---|---|---|
| Founded | N/A | 2016 |
| Country | China | Singapore |
| Employees | N/A | N/A |
| Industry | Precious Metals | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 4.4M |
| IPO Year | 1996 | 2023 |
| Metric | CHNR | MNDR |
|---|---|---|
| Price | $3.72 | $0.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 47.6K | ★ 149.1K |
| Earning Date | 05-15-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $608,852.40 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.16 | $0.66 |
| 52 Week High | $8.20 | $5.42 |
| Indicator | CHNR | MNDR |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 33.12 |
| Support Level | $3.35 | $0.68 |
| Resistance Level | $4.12 | $1.00 |
| Average True Range (ATR) | 0.39 | 0.07 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 18.25 | 8.00 |
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.